Across Protocol vs Venom — how do they compare? Across Protocol trades at Rp739.21 (market cap Rp505,3M, Rp188,8M 24h volume), while Venom trades at Rp333.71 (market cap Rp340,86M, Rp2,89M 24h volume). The key difference: Across Protocol is the larger of the two by market cap, and Across Protocol 's circulating supply is 716,5M / 1B ACX (72%) versus 988,9M / 8B VENOM (13%) for Venom. Which is the better fit depends on your goals — on Pluang, investors hold Across Protocol for 57 Days and Venom for 24 Days on average.
| ACX | VENOM | |
|---|---|---|
Market Cap | Rp505,3M | Rp340,86M |
Volume (24h) | Rp188,8M | Rp2,89M |
Circulating Supply | 716,5M / 1B ACX (72%) | 988,9M / 8B VENOM (13%) |
Typical Hold Time | 57 Days | 24 Days |
Signals from Pluang's Aura AI — not financial advice
Across Protocol (ACX) is trading at Rp728.43 with a market cap of Rp505.3M, showing bearish technical signals with 15 sell signals versus 3 buys. The token is near its pivot point of Rp714, with key support at Rp665 and resistance at Rp751. With 72% of max supply in circulation and average hold time of 57 days, the token shows moderate distribution. No major protocol updates or ecosystem developments have been reported recently.
Overall outlook remains cautious with bearish technical dominance. Key opportunity lies in oversold RSI conditions suggesting potential bounce, while major risks include low liquidity and concentrated sell pressure. Investors should monitor support levels closely and watch for any protocol developments that could shift momentum.
VENOM displays limited market activity with a modest market cap of Rp340.86M and only 13% of its maximum 8M token supply in circulation. The asset shows minimal trading volume and network activity, with an average hold time of 24 days indicating cautious investor behavior. No recent protocol updates or significant ecosystem developments have been observed, suggesting stagnant project growth.
Overall outlook remains cautious due to limited liquidity and adoption. Key opportunity lies in potential future protocol development, while major risks include extreme volatility from low market depth and regulatory uncertainty in the crypto space. Investors should monitor for any signs of renewed developer activity or exchange listings.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Across (ACX) is a cross-chain token bridge secured by UMA's optimistic oracle. Designed for capital efficiency, ACX features a single liquidity pool, competitive relayer options, and a no-slippage fee model. Because its oracle verifies transfers optimistically, ACX is able to process cross-chain transfers quickly.
Read more on ACX →Venom is a Layer 0 and Layer 1 network built on mesh technology that supports large-scale platforms like stablecoins and CBDCs. Its high scalability, speed, and low fees make it ideal for Web3 dApps, ensuring security and stability for high-load systems.
Read more on VENOM →